Selected Publication:
Trauner, M; Boyer, JL.
Cholestatic syndromes.
Curr Opin Gastroenterol. 1999; 15(3):217-228
Doi: 10.1097/00001574-199905000-00006
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Trauner Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Recent advances in cholestatic liver disease have occurred in several areas. Molecular cloning of hepatobiliary transport systems has resulted in the identification of the molecular basis of hereditary and acquired cholestatic syndromes. Apoptosis has been identified as an important mechanism of cholestatic liver injury and bile duct loss. New insights into the pathogenesis of pruritus and fatigue have resulted in new treatment strategies for these debilitating symptoms. Important new studies have been published about pathogenesis, clinical features, and treatment of primary biliary cirrhosis, primary sclerosing cholangitis, cholestasis of pregnancy, and drug-induced cholestasis.